Erasca (ERAS) Hits 4-Year High Ahead of ERAS-0015 Trial Results
Summary
Erasca rallied for a 5th straight session on Monday to hit a new four-year high, as investors positioned portfolios ahead of the results of its clinical study f...
Description
Erasca rallied for a 5th straight session on Monday to hit a new four-year high, as investors positioned portfolios ahead of the results of its clinical study f...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source